Illumina Body Map 2 (GSE30611)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
TGIF2 | hg38_v1_chr20_+_36574535_36574672 | 0.43 | 1.5e-02 | Click! |
PKNOX1 | hg38_v1_chr21_+_42974510_42974649 | 0.26 | 1.5e-01 | Click! |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 8.0 | GO:0045959 | regulation of complement activation, classical pathway(GO:0030450) negative regulation of complement activation, classical pathway(GO:0045959) |
0.5 | 7.6 | GO:2001300 | lipoxin metabolic process(GO:2001300) |
0.1 | 5.4 | GO:0006953 | acute-phase response(GO:0006953) |
0.8 | 5.1 | GO:0070295 | renal water absorption(GO:0070295) |
1.5 | 4.6 | GO:0002728 | negative regulation of natural killer cell cytokine production(GO:0002728) |
0.1 | 3.7 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.6 | 2.3 | GO:1990108 | protein linear deubiquitination(GO:1990108) |
0.1 | 2.2 | GO:1990416 | cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
0.2 | 2.1 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.6 | 1.9 | GO:0002302 | CD8-positive, alpha-beta T cell differentiation involved in immune response(GO:0002302) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 12.9 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.1 | 8.6 | GO:0044217 | other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.0 | 5.9 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.0 | 3.1 | GO:0097542 | ciliary tip(GO:0097542) |
0.1 | 2.6 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
0.0 | 2.6 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.1 | 2.3 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.0 | 2.2 | GO:0035580 | specific granule lumen(GO:0035580) |
0.0 | 2.0 | GO:0043204 | perikaryon(GO:0043204) |
0.1 | 1.7 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 8.2 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
1.5 | 7.6 | GO:0016404 | 15-hydroxyprostaglandin dehydrogenase (NAD+) activity(GO:0016404) |
0.7 | 5.1 | GO:0015254 | glycerol channel activity(GO:0015254) |
0.2 | 3.8 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
1.2 | 3.7 | GO:0005174 | CD40 receptor binding(GO:0005174) |
0.1 | 3.2 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.1 | 2.2 | GO:0016004 | phospholipase activator activity(GO:0016004) lipase activator activity(GO:0060229) |
0.0 | 2.1 | GO:0035064 | methylated histone binding(GO:0035064) |
0.3 | 1.9 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.0 | 1.9 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 13.4 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 4.6 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.1 | 4.3 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.0 | 4.1 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 3.8 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.0 | 3.2 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.0 | 2.6 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 2.4 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 2.0 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.0 | 1.8 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 10.8 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.3 | 9.0 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.0 | 5.4 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.3 | 5.1 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.1 | 4.7 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.1 | 3.8 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.1 | 3.2 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.0 | 2.5 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.1 | 1.6 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 1.6 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |